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Objective: To present the initial results of ﬁrst three years of implementation of a genetic
evaluation test for bone marrow-derived mesenchymal stem cells in a Cell Technology
Center.
Methods: A retrospective study was carried out of 21 candidates for cell therapy. After the
isolation of bone marrow mononuclear cells by density gradient, mesenchymal stem cells
were cultivated and expanded at least until the second passage. Cytogenetic analyses were
performed before and after cell expansion (62 samples) using G-banded karyotyping.
Results: All the samples analyzed, before and after cell expansion, had normal karyotypes,
showing no clonal chromosomal changes. Signs of chromosomal instability were observed
in 11 out of 21 patients (52%). From a total of 910 analyzed metaphases, ﬁve chromatid gaps,
six chromatid breaks and 14 tetraploid cells were detected giving as total of 25 metaphases
with chromosome damage (2.75%).
Conclusion: The absence of clonal chromosomal aberrations in our results for G-banded
karyotyping shows the maintenance of chromosomal stability of bone marrow-derived
mesenchymal stem cells until the second passage; however, signs of chromosomal instabil-
ity such as chromatid gaps, chromosome breaks and tetraploidy indicate that the long-term
cultivation of these cells can provide an intermediate step for tumorigenesis.© 2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.
may explain, at least in part, their tumorigenic potential.IntroductionCultivated stemcells (SC) have showngreat potential for use in
several areas of cell therapy, requiring, for their applicability,
strict quality control, safety and traceability. However, ex vivo
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reserved.expansionof these cells can lead to anaccumulationof genetic
and epigenetic alterations, featuring a genetic instability that
1,2o, Pontifícia Universidade Católica do Paraná (PUC-PR), Instituto
Differently from embryonic SC, where there have been
several reports of genetic abnormalities and tumor forma-
tion in mice,3–6 adult human SC, especially mesenchymal
e Terapia Celular. Published by Elsevier Editora Ltda. All rights
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C (MSC), seem to maintain their genetic stability during
ultivation,7 and therefore would not be susceptible to malig-
ant transformation.8,9
However, the observation that all cultivated cells develop
hromosomal aberrations over time, even those that are
ot SC,10 suggests that these cells, even adult cells, may
ave a potential tumorigenic transformation after in vitro
xpansion.11,12
Wang et al.13 developed two hypotheses for the presence
f transformed MSCs in a culture: a population of MSCs that
ave undergone transformation during cell culture, or the
resence of low frequencies of abnormal cells in the donor’s
one marrow (BM) that have expanded during the culture.
hese explanations could also be extended to MSC from other
ources because, in essence, the main fact is that cultivation
an create a favorable environment for transformed cells to
xpand and propagate in vitro.
The evaluation of the propensity for malignant transfor-
ation can and should be addressed by cytogenetic studies,
specially karyotyping, since the maintenance of a normal
aryotype is a reliable indicator of genetic stability of MSCs13
nd must be considered as a release criterion for the clinical
se of these cells.14
Although technical difﬁculties encourage researchers to
omplement their studies with techniques of molecular
ytogenetics, conventional cytogenetics (karyotyping through
-banding) is the most informative and considered the gold
tandard in the genetic evaluation of cell lines, allowing the
dentiﬁcation of both numerical and structural chromosomal
bnormalities.10,15,16
In Brazil, eight Cell Technology Centers (CTCs)were created
n 2008 with support from the Ministry of Health, contributing
o the development of these lines of research, ensuring quality
nd safety in new technologies related to cell therapy.
There is a widely reported concern in the literature, that in
itro cultivation of SC may be a risk factor for tumor forma-
ion. Thus, the Brazilian National Health Surveillance Agency
ANVISA), through a decree governing the operation of CTCs
RDC09/2011), requires the implementation of genetic control
s a release criterion for the use of these cells.
The aim of this study was to describe how the genetic
valuation test by G-banded karyotyping is performed at the
ontifícia Universidade Católica do Paraná (PUCPR). This type
CTC is authorized to culture and expand SC with its sanitary
ermit being granted on May 17th, 2012. In addition, the initial
esults of the ﬁrst three years of implementation of this test
or BM-derived MSC are presented.
ethods
atients and samples
retrospective study was carried out of 21 candidates for cell
herapy selected between December 2009 and December 2012.
ll patients enrolled in this study provided signed informed
onsent. This study was approved by national and local Ethics
ommittees (CONEP 03780084000-09, CEP 0005710/22 and
ONEP n197205, CEP 1370, 1371) and followed the criteria14;36(3):202–207 203
of the Helsinki convention. BM samples and the respective
MSCs were cultivated and evaluated at the CTC-PUCPR.
Culture of MSCs
After the isolation of BM mononuclear cells by density gradi-
ent and loading onto 1.077 g/mLHistopaque® (Sigma–Aldrich),
MSCs were cultivated in Iscove’s Modiﬁed Dulbecco’s Medium
(IMDM – GibcoTM) supplemented with 15% fetal bovine serum
(FBS – GibcoTM) in a humidiﬁed incubator with 5% carbon
dioxide at 37 ◦C. When the MSCs reached approximately 80%
of conﬂuence, they were dissociated using 0.25% trypsin-
ethylenediaminetetraacetic acid (EDTA – Sigma–Aldrich) and
continually expanded at least until the second passage (P2).
Samples were taken for cytogenetic studies, immunophe-
notyping and osteogenic, adipogenic and chondrogenic
differentiation assays,17,18 as recommended by the Interna-
tional Society for Cellular Therapy.19
G-banded karyotyping protocol
Cytogenetic analyses were performed before and after cell
expansion. Standard cytogenetic procedures were used in the
cytogenetic analysis of BM samples. To evaluate the MSC, a
literature-based protocol for ﬁbroblasts20 and SC from many
sources10,21 was developed in the CTC with modiﬁcations as
described below. When the culture reached a conﬂuence of
80%, Colcemid® (10mg/mL) was added to each ﬂask to a ﬁnal
dilution of 0.1g/mL and then incubated at 37 ◦C for 2–6h.
Changes in cell morphology were monitored using an inverted
microscope. The MSCs were detached using 2mL of heated
0.25% trypsin-EDTA. After 3min of monitored detachment,
two drops of FBS were added and the cells were transferred
to a centrifuge tube containing the medium. Samples were
centrifuged at 400× g for 10min. For the hypotonic treatment,
5mL of 0.075MKClwithHepeswas slowly and carefully added
followed by incubation at 37 ◦C for 30min and ﬁxation using
methanol:acetic acid (3:1) solution. To improve the quality of
metaphases, the sampleswerewashed twice in a cold solution
(5 ◦C) of fresh methanol:acetic acid (2:1). Prior to slide prepa-
ration, clean slides were placed in steam while the cells were
resuspended in fresh ﬁxative solution and dropped onto the
surface of the slide. In order to obtain G-bands, the slides were
aged at 60 ◦C for at least 16h. Then, they were immersed in
trypsin solution (0.002 g/mL) for 5 s, washed in saline solu-
tion and ﬁnally quickly rinsed in distilled water. The staining
procedure was carried out using Giemsa (1:20) or Wright (1:6)
solution, producing trypsin and Giemsa (GTG) or trypsin and
Wright (GTW) bands, respectively. The band quality was eval-
uated under the microscope (magniﬁcation: 100×) and the
trypsin and staining times were adjusted to produce clear well
stained bands.
Analysis and interpretation
Whenever possible, 20 metaphases were analyzed. To be con-
sidered a clone, the same structural alteration or the gain
of a particular chromosome had to be present in at least
two different metaphase cells, while the loss of a chro-
mosome should be detected in at least three cells. In the
204 rev bras hematol hemoter. 2014;36(3):202–207
Table 1 – Cytogenetic results detected in bone marrow cells (BM) and mesenchymal stem cells (MSC).
Patient Before cell expansion (BM) After cell expansion (MSC)
Karyotype Chromosomal
instability
signs
Samples
analyzed
(passages)
Number of
metaphases
analyzed
Chromosomal
instability
signs
1 46,XX [20] – P0,P1, P2 19 4n [1]
2 46,XY [35] – P0,P1, P2 51 –
3 46,XY [20] – P1, P2,P3 22 –
4 46,XY [12] – P0,P1, P2,P3 64 4n [1], chtg [3]
5 46,XY,inv(9)(p12q13) [15] – P0,P1, P2,P3 15 4n [2]
6 46,XY [20] – P2 20 4n [1]
7 46,XY [20] – P2 57 –
8 46,XY [20] – P2 32 –
9 46,XY [10] – P2,P3 11 –
10 46,XX [8] – P0,P1, P2,P3 11 –
11 46,XY [18] – P1, P2,P3 21 –
12 46,XY [20] – P3,P4 42 –
13 46,XY [30] chtb (9q) [1], chtg [1] P2 22
14 46,XY [20] 4n [1], chtb (3q)[1] P2, P3 20 –
15 46,XX [20] – P2 15 –
16 46,XY [20] 4n[3] P2 20 –
17 46,XY [20] 4n [1] P2 20 4n [1], chtb (10q) [1]
18 46,XX [20] – P2 20 4n [2]
19 46,XY [20] – P2 20 –
20 46,XY [20] chtb [1], chtg [1] P2 20 4n [1]
21 46,XX [20] – P2 20 chtb (1q)[1], chtb(22q)[1]
Total metaphases 408 10 502 15chtg: chromatid gap; chtb: chromatid break; 4n: tetraploid cell.
International System for Human Cytogenetic Nomenclature
(2013), the recommendations related to abnormalities in neo-
plasia, non-clonal aberrations should not be part of the
description of the karyotype.22
Results
A total of 21 patients with a mean age 53±9.25 years were
evaluated, of which 16 were male. The total number of sam-
ples was 62, with 21 being BM samples and 41 MSC cultivated
until the second passage and, in some cases, until the fourth
passage (P4) (Table 1).
Metaphases were successfully obtained in all cases and all
were identiﬁed as normal diploid karyotypes, although many
metaphases presented monosomy (non-clonal) in different
chromosomes.
The samples analyzed before cell expansion, with BM cells,
had a normal karyotype, showing no clonal chromosomal
changes. One case showed inv(9)(p12q13), considered a nor-
mal variation in the population. All samples had cells with
random chromosome losses.
Samples analyzed after cell expansion maintained normal
karyotypes without the appearance of acquired clonal chro-
mosomal abnormalities (Figure 1). All samples had cells with
random chromosome losses.
Signs of chromosomal instability were observed in 11 (52%)
out of 21 patients. From a total of 910 analyzed metaphases,
ﬁve chromatid gaps, six chromatid breaks (Figure 2) and 14
tetraploid cells were detected giving a total of 25 metaphases
with chromosome damage (2.75%).A small fraction of these cells showed diplochromosomes
(Figure 3).
No clonal chromosomal rearrangements were detected. All
the samples were approved by the cytogenetic quality control
for autologous therapeutic use.
Discussion
Standardization for stem cell studies
The presence of aneuploid cellswith non-clonal chromosomal
losses should be related to the adjustment of hypotonic solu-
tion exposure: short hypotonic exposure may not be sufﬁcient
for a good dispersion of metaphasic chromosomes, resulting
in many overlapping chromosomes, whereas overexposure
can weaken the plasma membrane, eventually resulting in
disruption and loss of some chromosomes.20 The hypotonic
treatment, therefore, is critical for the karyotyping test, and
its standardization is crucial to correctly interpret results. In
arresting mitotic division, unlike BM cells or peripheral blood
(stimulated), cultures of adherent cells require longer periods
of colchicine to compensate for the slower growth rate. How-
ever, there is a dose-dependent effect that may change the
quality of chromosomes, such as their length, shape and dis-
tribution of chromatids. In the current study, less than 1h of
mitotic inhibition was not sufﬁcient to deliver a reasonable
number ofmetaphases, whilemore than 6h affected the qual-
ity of chromosomes. In order to optimize metaphase quality,
MSCs were obtained using a 3:1 methanol:acetic acid solution,
followed by additional washes with higher concentrations of
rev bras hematol hemoter. 2014;36(3):202–207 205
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cetic acid (2:1). For G-band staining (GTG or GTW), a higher
han usual trypsin concentration was required, which should
e of at least 0.002 g/mL, with an exposure time ranging from 5
o 20 s, depending on the situation and conditions during the
reparation of the slides.
hromosomal instability and tumorigenic potential
he high frequency of chromosomal alterations may be a pre-
equisite for an oncogenetic process that involves multiple
enetic steps, such as the inactivation of tumor suppres-
or genes and ampliﬁcation of oncogenes,23 although the
ccurrence of aneuploid cells (with numerical chromosomal
nomalies) is not necessarily associated with the transforma-
ion:MSCs,with orwithout chromosomal abnormalities, show
rowth arrest and enter senescence.24In this study, no clonal chromosomal aberrations were
dentiﬁed in any of the analyzed cases; however, several signs
igure 2 – Case 20; bone marrow. Partial karyogram
howing chromatid breaks in the long arm of chromosome
.sage 2. Normal complete karyogram (46,XY).
of chromosomal instability were observed including chro-
matid gaps, chromosomal breaks and tetraploid metaphases.
It is well known that the presence of gaps and breaks,
a characteristic of syndromes of chromosomal instability,
increases the risk for neoplastic diseases. Therefore, the
presence of these signs in cultured SC is evidence of their
tumorigenic potential. On comparing before and after culti-
vation, there was no evidence of an increase in the signs of
instability. However, increases in genetic instability probably
depend on the time of cultivation. Binato et al.25 demon-
strated, for example, the maintenance of genetic stability up
to P4, but several genetic changes were seen from P5 onward
underscoring the fact that, for the use of cells fromhigher pas-
sages, it is necessary to analyze case by case. Tetraploidy, i.e.
cells with duplicated genetic material, is a well-documented
phenomenon in cultivated cells: it occurs at a frequency of
3–5% in cultured human ﬁbroblasts. A small fraction of these
cells may show diplochromosomes, which appear only in the
ﬁrst division after endoreduplication26 as was detected in this
Figure 3 – Case 05; mesenchymal stem cells – Passage 1.
Metaphase showing diplochromosome.
oter.
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study (Figure 3). This phenomenon has also been reported in
cultured SC: Grimes et al.27 detected a frequency of 11.6% of
tetraploids in chorionic villous-derived cells. In our sample,
this frequency was 1.78%. The problem of the appearance of
these cells is that they are related to an error during mito-
sis (regression of the cleavage furrow), which, in turn, may
lead in future divisions and to the emergence of aneuploid
cells. Therefore, these cells are genetically unstable and there
is evidence that they can act as an intermediate step for
tumorigenesis.28,29
Interestingly, these abnormal mitotic mechanisms are
described in the progression of malignant mesenchymal
tumors, where the increased frequency of chromosomal aber-
rations can be explained by a process initiated by telomere
dysfunction and anaphasic bridges, which, in turn, can deter-
mine an increased frequency of multinucleated cells through
cytokinesis failure.30
The absence of clonal chromosomal aberrations in BM-
derived MSC had already been described in a sample of ten
healthy hematopoietic SC donors with a median age of 18
years.7 Our results conﬁrm the maintenance of the stability of
these cells until P2 in a representative sample of candidates
for cell therapy with a mean age of 53 years.
Conclusions
Our results conﬁrm the importance of the G-band cytogenetic
study, since this technique is able to detect both numeric and
structural alterations, includingbalanced rearrangements and
mosaicism, besides evidencing signs of ‘instability’.
The absence of clonal chromosomal aberrations among our
results for G-banded karyotyping shows the maintenance of
chromosomal stability of the BM-derivedMSCuntil the second
passage; however, signs of chromosomal instability such as
chromatid gaps, chromosome breaks and tetraploidy indicate
that the long-term cultivation of these cells can provide an
intermediate step for tumorigenesis.
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